JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258021

Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LAMTOR3 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon5 and 58 bp deletion in exon5.

View Alternative Names

LAMTOR3, LTOR3_HUMAN, Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3, MEK partner 1, MEK-binding partner 1, Mitogen-activated protein kinase kinase 1-interacting protein 1, Mitogen-activated protein kinase scaffold protein 1, Mp1, Ragulator complex protein LAMTOR3

3 Images
Western blot - Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell lysate (AB258021)
  • WB

Lab

Western blot - Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell lysate (AB258021)

Lane 1 : Wild-type HeLa cell lysate (20 μg)

Lane 2 : LAMTOR3 knockout HeLa cell lysate (20 μg)

Lanes 1-2 : Merged signal (red and green). Green - ab32134 observed at 14 kDa. Red - loading control ab8245 observed at 37 kDa.

ab32134 Anti-MAP2K1IP1 antibody [Y130] was shown to specifically react with MAP2K1IP1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265624 (knockout cell lysate ab258021) was used. Wild-type and MAP2K1IP1 knockout samples were subjected to SDS-PAGE. ab32134 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 50000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-MAP2K1IP1 antibody [Y130] (<a href='/en-us/products/primary-antibodies/map2k1ip1-antibody-y130-ab32134'>ab32134</a>) at 1/50000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

MAP2K1IP1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-lamtor3-map2k1ip1-knockout-hela-cell-line-ab265624'>ab265624</a>)

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Predicted band size: 14 kDa

Observed band size: 14 kDa

false

Sanger Sequencing - Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell lysate (AB258021)
  • Sanger seq

Unknown

Sanger Sequencing - Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell lysate (AB258021)

Allele-1 : 58 bp deletion in exon5

Sanger Sequencing - Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell lysate (AB258021)
  • Sanger seq

Unknown

Sanger Sequencing - Human LAMTOR3 (MAP2K1IP1) knockout HeLa cell lysate (AB258021)

Allele-2 : 1 bp insertion in exon5

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon5 and 58 bp deletion in exon5.

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258021-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LAMTOR3 knockout HeLa cell lysate", "number":"AB258021-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258021-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LAMTOR3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com